Unknown NA INTERVENTIONAL 1-arm NCT01334684

Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes

White Blood Cells Gene Expression Profiles as a Tool for Predicting Metformin Efficacy in Patients With Type 2 Diabetes Mellitus

Sponsor: Casa Sollievo della Sofferenza IRCCS

Conditions Type 2 Diabetes

Interventions Metformin

Updated 4 times since 2017 Last updated: Apr 12, 2011 Started: May 31, 2011 Primary completion: Apr 30, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01334684, this NA trial focuses on Type 2 Diabetes and remains ongoing. Sponsored by Casa Sollievo della Sofferenza IRCCS, it has been updated 4 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jan 2017 — Jan 2021 [monthly]

Unknown Status NA

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Casa Sollievo della Sofferenza IRCCS
University Hospital, Catania

Data source: Casa Sollievo della Sofferenza IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Giovanni Rotondo, Italy